Breaking News Instant updates and real-time market news.

AMP

Ameriprise

$146.71 /

+2.1 (+1.45%)

09:05
09/28/20
09/28
09:05
09/28/20
09:05

Ameriprise sees Q3 adjusted operating earnings to include $350M impact

Ameriprise Financial announced that the company estimates its third quarter 2020 adjusted operating earnings will include an unfavorable impact of approximately $350M after-tax resulting from its annual review of insurance and annuity valuation assumptions and models. The non-cash unfavorable impact primarily reflects the low interest rate environment, as the reduction of the company's 10-year Treasury rate assumption to 3.5% and extending the grading period to 6.5 years with no grading in 2020 accounts for the vast majority of the impact. The change in interest rate assumptions will have no impact on excess capital as it is determined on a statutory basis. For the full year, the company continues to estimate that its operating effective tax rate will be in the 16% to 18% range. The company estimates its operating effective tax rate in the third quarter of 2020 will be elevated as a result of the unlocking, as well as the impact of hedging.

AMP Ameriprise
$146.71 /

+2.1 (+1.45%)

09/28/20 Credit Suisse
Ameriprise price target lowered to $194 from $200 at Credit Suisse
08/13/20 Barclays
Ameriprise initiated with an Overweight at Barclays
06/25/20
Fly Intel: Top five analyst upgrades
06/25/20 Goldman Sachs
Ameriprise upgraded to Buy from Neutral at Goldman Sachs

TODAY'S FREE FLY STORIES

Hot Stocks
HighPoint Resources announces 1-for-50 reverse stock split » 08:19
10/20/20
10/20
08:19
10/20/20
08:19
HPR

HighPoint Resources

$0.19 /

-0.0201 (-9.57%)

HighPoint Resources…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
HPR HighPoint Resources
$0.19 /

-0.0201 (-9.57%)

HPR HighPoint Resources
$0.19 /

-0.0201 (-9.57%)

04/07/20 Imperial Capital
HighPoint Resources price target lowered to 50c from $1.50 at Imperial Capital
03/09/20 SunTrust
HighPoint Resources downgraded to Hold from Buy at SunTrust
02/28/20 Imperial Capital
HighPoint Resources downgraded to In-Line from Outperform at Imperial Capital
HPR HighPoint Resources
$0.19 /

-0.0201 (-9.57%)

Hot Stocks
Neoleukin Therapeutics appoints Holly Vance as general counsel » 08:18
10/20/20
10/20
08:18
10/20/20
08:18
NLTX

Neoleukin Therapeutics

$12.31 /

-0.14 (-1.12%)

Neoleukin announced the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NLTX Neoleukin Therapeutics
$12.31 /

-0.14 (-1.12%)

NLTX Neoleukin Therapeutics
$12.31 /

-0.14 (-1.12%)

09/22/20 Baird
Baird starts 'pioneer' Neoleukin Therapeutics at Outperform
09/22/20 Baird
Neoleukin Therapeutics initiated with an Outperform at Baird
08/12/20 Piper Sandler
Neoleukin Therapeutics price target raised to $30 from $28 at Piper Sandler
06/24/20 Piper Sandler
Neoleukin Therapeutics price target raised to $28 from $20 at Piper Sandler
NLTX Neoleukin Therapeutics
$12.31 /

-0.14 (-1.12%)

  • 02
    Jul
  • 18
    Dec
NLTX Neoleukin Therapeutics
$12.31 /

-0.14 (-1.12%)

Recommendations
Morgan Stanley sees more upside as likely for Chegg » 08:17
10/20/20
10/20
08:17
10/20/20
08:17
CHGG

Chegg

$86.38 /

+1.95 (+2.31%)

Ahead of earnings from…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CHGG Chegg
$86.38 /

+1.95 (+2.31%)

CHGG Chegg
$86.38 /

+1.95 (+2.31%)

09/24/20 KeyBanc
Initial enrollment data from NSCRC 'positive' for Chegg, says KeyBanc
08/26/20 Piper Sandler
Chegg initiated with an Overweight at Piper Sandler
08/04/20 Barrington
Chegg price target raised to $95 from $60 at Barrington
08/04/20 Citi
Citi upgrades Chegg to Buy with $100 target after Q2 beat
CHGG Chegg
$86.38 /

+1.95 (+2.31%)

CHGG Chegg
$86.38 /

+1.95 (+2.31%)

CHGG Chegg
$86.38 /

+1.95 (+2.31%)

CHGG Chegg
$86.38 /

+1.95 (+2.31%)

Earnings
Osisko Gold reports preliminary Q3 revenues C$55.7M, consensus C$59.25M » 08:17
10/20/20
10/20
08:17
10/20/20
08:17
OR

Osisko Gold

$11.83 /

-0.18 (-1.50%)

Osisko Gold Royalties…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
OR Osisko Gold
$11.83 /

-0.18 (-1.50%)

OR Osisko Gold
$11.83 /

-0.18 (-1.50%)

10/13/20 Scotiabank
Osisko Gold price target raised to C$24 from C$21 at Scotiabank
09/16/20 CIBC
Osisko Gold price target raised to C$19.75 from C$17.50 at CIBC
09/11/20 National Bank
Osisko Gold price target raised to C$22 from C$21 at National Bank
08/07/20 Raymond James
Osisko Gold price target raised to C$19 from C$17.50 at Raymond James
Conference/Events
Cara Therapeutics to host conference call » 08:15
10/20/20
10/20
08:15
10/20/20
08:15
GNHAF

Vifor Pharma

$0.00 /

+ (+0.00%)

, CARA

Cara Therapeutics

$13.94 /

-0.07 (-0.50%)

Conference call to…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GNHAF Vifor Pharma
$0.00 /

+ (+0.00%)

CARA Cara Therapeutics
$13.94 /

-0.07 (-0.50%)

GNHAF Vifor Pharma
$0.00 /

+ (+0.00%)

09/04/20 Stifel
Vifor Pharma price target lowered to CHF 158 from CHF 160 at Stifel
09/02/20 Barclays
Vifor Pharma price target lowered to CHF 140 from CHF 155 at Barclays
08/26/20 Deutsche Bank
Vifor Pharma price target lowered to CHF 150 from CHF 160 at Deutsche Bank
08/13/20 UBS
Vifor Pharma price target lowered to CHF 142 from CHF 149 at UBS
CARA Cara Therapeutics
$13.94 /

-0.07 (-0.50%)

04/22/20 Cantor Fitzgerald
Cara Therapeutics price target raised to $34 from $26 at Cantor Fitzgerald
04/21/20 H.C. Wainwright
Cara Therapeutics price target raised to $33 from $30 at H.C. Wainwright
01/10/20 Stifel
Cara Therapeutics named a BioPharma top pick for 2020 at Stifel
12/19/19 Piper Jaffray
Cara Therapeutics risk/reward 'compelling' at these levels, says Piper Jaffray
CARA Cara Therapeutics
$13.94 /

-0.07 (-0.50%)

CARA Cara Therapeutics
$13.94 /

-0.07 (-0.50%)

Recommendations
Cadence Design price target raised to $135 from $120 at Wells Fargo » 08:15
10/20/20
10/20
08:15
10/20/20
08:15
CDNS

Cadence Design

$113.46 /

-2.22 (-1.92%)

Wells Fargo analyst Gary…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CDNS Cadence Design
$113.46 /

-2.22 (-1.92%)

CDNS Cadence Design
$113.46 /

-2.22 (-1.92%)

08:03 Today DA Davidson
Cadence Design price target raised to $130 from $120 at DA Davidson
07:46 Today Needham
Cadence Design price target raised to $126 from $115 at Needham
07:33 Today RBC Capital
Cadence Design price target raised to $127 from $122 at RBC Capital
07/21/20 Wells Fargo
Cadence Design price target raised to $120 from $110 at Wells Fargo
CDNS Cadence Design
$113.46 /

-2.22 (-1.92%)

CDNS Cadence Design
$113.46 /

-2.22 (-1.92%)

CDNS Cadence Design
$113.46 /

-2.22 (-1.92%)

Hot Stocks
NMI Holdings announces $242M insurance-linked notes transaction » 08:15
10/20/20
10/20
08:15
10/20/20
08:15
NMIH

NMI Holdings

$23.08 /

+0.08 (+0.35%)

NMI Holdings announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NMIH NMI Holdings
$23.08 /

+0.08 (+0.35%)

NMIH NMI Holdings
$23.08 /

+0.08 (+0.35%)

10/12/20 Susquehanna
Earning should propel mortgage insurers higher, says Susquehanna
10/09/20 B. Riley Securities
NMI Holdings price target raised to $26 from $20 at B. Riley Securities
10/09/20 JPMorgan
NMI Holdings price target raised to $23.50 from $18.50 at JPMorgan
08/14/20 Citi
NMI Holdings initiated with a Buy at Citi
NMIH NMI Holdings
$23.08 /

+0.08 (+0.35%)

  • 04
    Jun
NMIH NMI Holdings
$23.08 /

+0.08 (+0.35%)

NMIH NMI Holdings
$23.08 /

+0.08 (+0.35%)

General news
Housing Starts and Permits to be reported at 08:30 » 08:15
10/20/20
10/20
08:15
10/20/20
08:15

September Housing Starts…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Hot Stocks
FIS secures domestic card scheme acquiring licenses in Argentina » 08:14
10/20/20
10/20
08:14
10/20/20
08:14
FIS

FIS

$139.63 /

-4.2 (-2.92%)

FIS announced the latest…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FIS FIS
$139.63 /

-4.2 (-2.92%)

FIS FIS
$139.63 /

-4.2 (-2.92%)

07:47 Today JPMorgan
FIS price target raised to $170 from $168 at JPMorgan
10/06/20 Credit Suisse
Fiserv upgraded to Outperform at Credit Suisse on improving mix and valuation
09/22/20 Loop Capital
FIS initiated with a Hold at Loop Capital
09/16/20 Compass Point
FIS initiated with a Neutral at Compass Point
FIS FIS
$139.63 /

-4.2 (-2.92%)

FIS FIS
$139.63 /

-4.2 (-2.92%)

Hot Stocks
Opko Health's BioReference Labs launches multiplex COVID-19, influenza A/B test » 08:14
10/20/20
10/20
08:14
10/20/20
08:14
OPK

Opko Health

$4.60 /

+0.305 (+7.11%)

BioReference…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
OPK Opko Health
$4.60 /

+0.305 (+7.11%)

OPK Opko Health
$4.60 /

+0.305 (+7.11%)

07/31/20 Piper Sandler
Opko Health price target raised to $10 from $6 at Piper Sandler
07/08/20 Piper Sandler
Opko Health price target raised to $6 from $4 at Piper Sandler
06/09/20 Piper Sandler
Opko Health price target raised to $4 from $3 at Piper Sandler
06/08/20 Piper Sandler
Opko Health, Pfizer data show IGF-1 normal at ENDO, says Piper Sandler
OPK Opko Health
$4.60 /

+0.305 (+7.11%)

  • 25
    Oct
OPK Opko Health
$4.60 /

+0.305 (+7.11%)

OPK Opko Health
$4.60 /

+0.305 (+7.11%)

OPK Opko Health
$4.60 /

+0.305 (+7.11%)

Hot Stocks
CNS' U.S. manufacturer completes manufacturing process for Berubicin » 08:14
10/20/20
10/20
08:14
10/20/20
08:14
CNSP

CNS Pharmaceuticals

$1.80 /

-0.03 (-1.64%)

CNS Pharmaceuticals…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CNSP CNS Pharmaceuticals
$1.80 /

-0.03 (-1.64%)

CNSP CNS Pharmaceuticals
$1.80 /

-0.03 (-1.64%)

08/24/20 Ladenburg
CNS Pharmaceuticals initiated with a Buy at Ladenburg
12/04/19 Benchmark
CNS Pharmaceuticals initiated with a Speculative Buy at Benchmark
  • 08
    Nov
Hot Stocks
Lincoln Educational reports Q3 student starts up 15% » 08:13
10/20/20
10/20
08:13
10/20/20
08:13
LINC

Lincoln Educational

$4.72 /

-0.17 (-3.48%)

Lincoln Educational…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
LINC Lincoln Educational
$4.72 /

-0.17 (-3.48%)

LINC Lincoln Educational
$4.72 /

-0.17 (-3.48%)

09/10/20 Canaccord
Lincoln Educational offerings solid, Canaccord initiates with a Buy
09/10/20 Canaccord
Lincoln Educational initiated with a Buy at Canaccord
08/11/20 Barrington
Lincoln Educational price target raised to $7 from $4 at Barrington
06/23/20 Colliers
Lincoln Educational initiated with a Buy at Colliers
LINC Lincoln Educational
$4.72 /

-0.17 (-3.48%)

Hot Stocks
Keros Therapeutics doses first participants in Phase 2 trial of KER-050 » 08:12
10/20/20
10/20
08:12
10/20/20
08:12
KROS

Keros Therapeutics

$50.58 /

-1.45 (-2.79%)

Keros Therapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
KROS Keros Therapeutics
$50.58 /

-1.45 (-2.79%)

KROS Keros Therapeutics
$50.58 /

-1.45 (-2.79%)

09/13/20 Piper Sandler
Keros Therapeutics price target raised to $55 from $45 at Piper Sandler
08/13/20 Piper Sandler
Keros heading towards multiple Phase II studies, says Piper Sandler
06/12/20 Piper Sandler
Keros Therapeutics' EHA data bode well for KER-050, says Piper Sandler
05/27/20 Piper Sandler
Keros Therapeutics price target raised to $45 from $35 at Piper Sandler
KROS Keros Therapeutics
$50.58 /

-1.45 (-2.79%)

  • 08
    Apr
KROS Keros Therapeutics
$50.58 /

-1.45 (-2.79%)

Hot Stocks
Seaborn deploys Infinera to launch AMX-1 submarine network services » 08:11
10/20/20
10/20
08:11
10/20/20
08:11
INFN

Infinera

$6.77 /

+0.07 (+1.04%)

Infinera and Seaborn…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
INFN Infinera
$6.77 /

+0.07 (+1.04%)

INFN Infinera
$6.77 /

+0.07 (+1.04%)

09/04/20 B. Riley FBR
Infinera, Extreme, Viavi selloffs yesterday overdone, says B. Riley FBR
09/04/20 Morgan Stanley
Ciena price target lowered to $46 from $50 at Morgan Stanley
08/17/20
Fly Intel: Top five analyst upgrades
08/17/20 Stifel
Infinera upgraded to Buy from Hold at Stifel
INFN Infinera
$6.77 /

+0.07 (+1.04%)

INFN Infinera
$6.77 /

+0.07 (+1.04%)

INFN Infinera
$6.77 /

+0.07 (+1.04%)

Hot Stocks
AstraZeneca's Tagrisso gets FDA acceptance for sNDA for NSCLC treatment » 08:10
10/20/20
10/20
08:10
10/20/20
08:10
AZN

AstraZeneca

$52.44 /

-0.58 (-1.09%)

AstraZeneca's…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AZN AstraZeneca
$52.44 /

-0.58 (-1.09%)

AZN AstraZeneca
$52.44 /

-0.58 (-1.09%)

10/08/20 JPMorgan
AstraZeneca FY20 guide could look conservative after Q3 results, says JPMorgan
10/06/20 Raymond James
Raymond James says FDA guidance 'likely assures' no vaccine EUA before late Nov.
09/29/20 Berenberg
AstraZeneca initiated with a Buy at Berenberg
09/28/20 Maxim
Maxim upgrades Inovio to Buy, says shares oversold after vaccine 'speed bump'
AZN AstraZeneca
$52.44 /

-0.58 (-1.09%)

AZN AstraZeneca
$52.44 /

-0.58 (-1.09%)

AZN AstraZeneca
$52.44 /

-0.58 (-1.09%)

AZN AstraZeneca
$52.44 /

-0.58 (-1.09%)

Hot Stocks
Hormel Foods appoints Pierre Lilly as Chief Compliance Officer » 08:10
10/20/20
10/20
08:10
10/20/20
08:10
HRL

Hormel Foods

$49.01 /

-0.55 (-1.11%)

Hormel Foods announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
HRL Hormel Foods
$49.01 /

-0.55 (-1.11%)

HRL Hormel Foods
$49.01 /

-0.55 (-1.11%)

09/08/20 Seaport Global
Hormel Foods initiated with a Neutral at Seaport Global on valuation
09/08/20 Seaport Global
Hormel Foods initiated with a Neutral at Seaport Global
07/17/20
Fly Intel: Top five analyst initiations
07/17/20 Argus
Hormel Foods initiated with a Buy at Argus
HRL Hormel Foods
$49.01 /

-0.55 (-1.11%)

HRL Hormel Foods
$49.01 /

-0.55 (-1.11%)

HRL Hormel Foods
$49.01 /

-0.55 (-1.11%)

Hot Stocks
Huami announces strategic cooperation agreement with Xiaomi » 08:10
10/20/20
10/20
08:10
10/20/20
08:10
HMI

Huami

$11.88 /

-0.39 (-3.18%)

Huami announced a 3-year…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
HMI Huami
$11.88 /

-0.39 (-3.18%)

Recommendations
BJ's Restaurants price target raised to $29 from $23 at Wells Fargo » 08:10
10/20/20
10/20
08:10
10/20/20
08:10
BJRI

BJ's Restaurants

$32.63 /

+0.1 (+0.31%)

Wells Fargo analyst Jon…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BJRI BJ's Restaurants
$32.63 /

+0.1 (+0.31%)

BJRI BJ's Restaurants
$32.63 /

+0.1 (+0.31%)

09/22/20 CL King
BJ's Restaurants price target raised to $37 from $33 at CL King
09/14/20 Piper Sandler
BJ's Restaurants price target raised to $39 from $28 at Piper Sandler
07/24/20 Stephens
BJ's Restaurants price target raised to $23 from $20 at Stephens
07/16/20 Loop Capital
BJ's Restaurants downgraded to Hold from Buy at Loop Capital
BJRI BJ's Restaurants
$32.63 /

+0.1 (+0.31%)

BJRI BJ's Restaurants
$32.63 /

+0.1 (+0.31%)

Hot Stocks
Kratos Defense introduces OpenSpace software platform » 08:10
10/20/20
10/20
08:10
10/20/20
08:10
KTOS

Kratos Defense

$20.64 /

-0.14 (-0.67%)

Kratos Defense &…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
KTOS Kratos Defense
$20.64 /

-0.14 (-0.67%)

KTOS Kratos Defense
$20.64 /

-0.14 (-0.67%)

09/23/20 Benchmark
Benchmark says Microsoft partnership can be 'big driver' for Kratos
09/22/20
Fly Intel: Top five analyst downgrades
09/22/20 JPMorgan
Kratos Defense downgraded to Neutral on valuation at JPMorgan
09/22/20 JPMorgan
Kratos Defense downgraded to Neutral from Overweight at JPMorgan
KTOS Kratos Defense
$20.64 /

-0.14 (-0.67%)

  • 19
    Jun
KTOS Kratos Defense
$20.64 /

-0.14 (-0.67%)

KTOS Kratos Defense
$20.64 /

-0.14 (-0.67%)

KTOS Kratos Defense
$20.64 /

-0.14 (-0.67%)

Hot Stocks
Evofem: First patient enrolled in pivotal Phase 3 trial of EVO100 » 08:09
10/20/20
10/20
08:09
10/20/20
08:09
EVFM

Evofem

$2.83 /

-0.02 (-0.70%)

Evofem Biosciences…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
EVFM Evofem
$2.83 /

-0.02 (-0.70%)

EVFM Evofem
$2.83 /

-0.02 (-0.70%)

10/01/20 Stifel
Evofem initiated with a Buy at Stifel
08/20/20 Morgan Stanley
Evofem initiated with an Equal Weight at Morgan Stanley
08/20/20 Morgan Stanley
Evofem initiated with an Equal Weight at Morgan Stanley
08/10/20 Oppenheimer
Evofem price target raised to $25 from $18 at Oppenheimer
EVFM Evofem
$2.83 /

-0.02 (-0.70%)

  • 03
    Jun
EVFM Evofem
$2.83 /

-0.02 (-0.70%)

EVFM Evofem
$2.83 /

-0.02 (-0.70%)

Hot Stocks
GrowGeneration acquires BGT chain in Michigan » 08:09
10/20/20
10/20
08:09
10/20/20
08:09
GRWG

GrowGeneration

$18.42 /

+1.005 (+5.77%)

GrowGeneration announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GRWG GrowGeneration
$18.42 /

+1.005 (+5.77%)

GRWG GrowGeneration
$18.42 /

+1.005 (+5.77%)

10/12/20 Lake Street
GrowGeneration deal brings 11th state of operation, says Lake Street
10/02/20 Oppenheimer
GrowGeneration strategy taking shape, says Oppenheimer
09/18/20 Roth Capital
GrowGeneration price target raised to $20 from $14 at Roth Capital
08/28/20 Oppenheimer
GrowGeneration price target raised to $25 from $15 at Oppenheimer
GRWG GrowGeneration
$18.42 /

+1.005 (+5.77%)

  • 30
    Jun
GRWG GrowGeneration
$18.42 /

+1.005 (+5.77%)

GRWG GrowGeneration
$18.42 /

+1.005 (+5.77%)

GRWG GrowGeneration
$18.42 /

+1.005 (+5.77%)

Hot Stocks
Axonics launches ARTISTRY study for Axonics r-SNM System patients » 08:09
10/20/20
10/20
08:09
10/20/20
08:09
AXNX

Axonics

$47.64 /

-0.5 (-1.04%)

Axonics has launched a…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AXNX Axonics
$47.64 /

-0.5 (-1.04%)

AXNX Axonics
$47.64 /

-0.5 (-1.04%)

09/29/20 Morgan Stanley
Survey indicates Street too conservative on Axonics, says Morgan Stanley
09/02/20 Baird
Axonics initiated with an Outperform at Baird
08/04/20 Piper Sandler
Proposed CMS rates positive for neuromodulation names, says PiperSandler
08/03/20 Piper Sandler
Piper says Axonics positioned for continued share taking despite Medtronic nod
AXNX Axonics
$47.64 /

-0.5 (-1.04%)

  • 08
    May
  • 20
    Nov
AXNX Axonics
$47.64 /

-0.5 (-1.04%)

Hot Stocks
ATIF Holdings signs LOI to acquire Xi'an Green Fun Technology » 08:09
10/20/20
10/20
08:09
10/20/20
08:09
ATIF

ATIF Holdings

$1.38 /

-0.05 (-3.50%)

ATIF Holdings announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ATIF ATIF Holdings
$1.38 /

-0.05 (-3.50%)

Recommendations
AptarGroup price target raised to $135 from $130 at Wells Fargo » 08:08
10/20/20
10/20
08:08
10/20/20
08:08
ATR

AptarGroup

$115.19 /

-1.35 (-1.16%)

Wells Fargo analyst Gabe…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ATR AptarGroup
$115.19 /

-1.35 (-1.16%)

ATR AptarGroup
$115.19 /

-1.35 (-1.16%)

10/14/20 Seaport Global
AptarGroup initiated with a Neutral at Seaport Global
08/03/20 Wells Fargo
AptarGroup price target raised to $130 from $118 at Wells Fargo
08/03/20 Deutsche Bank
AptarGroup price target raised to $127 from $118 at Deutsche Bank
04/27/20 BofA
AptarGroup upgraded to Buy from Neutral at BofA
ATR AptarGroup
$115.19 /

-1.35 (-1.16%)

Hot Stocks
ATIF Holdings signs LOI to acquire 51% equity interest in Green Fun » 08:08
10/20/20
10/20
08:08
10/20/20
08:08
ATIF

ATIF Holdings

$1.38 /

-0.05 (-3.50%)

ATIF Holdings announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ATIF ATIF Holdings
$1.38 /

-0.05 (-3.50%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.